Background {#Sec1}
==========

Type 2 diabetes mellitus (T2DM), characterized by chronic hyperglycemia caused by insufficient responses to insulin, is the most prevalent type of metabolic disorder, and it is estimated that over 344 million people are currently affected by this disease worldwide \[[@CR1], [@CR2]\]. So far, the exact pathogenesis of T2DM is still not fully understood. However, past genome-wide association studies already identified over 100 genetic loci that were significantly associated with an increased susceptibility to T2DM, which supported that inherit factors were crucial for its occurrence and development \[[@CR3], [@CR4]\].

Transcription Factor 7 Like 2 (*TCF7L2*) gene encodes T cell transcription factor 4, a transcription factor of the Wnt/β-catenin signaling pathway that is vital for embryogenesis of the pancreas islet and regulation of blood glucose \[[@CR5], [@CR6]\]. Recently, some genome-wide association studies found that *TCF7L2* rs7903146 polymorphism could significantly affect individual susceptibility to T2DM in certain populations \[[@CR7], [@CR8]\]. Since then, many genetic association studies were performed in diverse populations to estimate potential associations between *TCF7L2* rs7903146 polymorphism and T2DM, with inconsistent results. In 2018, Ding et al. \[[@CR9]\] already performed a meta-analysis to assess association between *TCF7L2* rs7903146 polymorphism and T2DM, but only 28 studies were included by the authors and many eligible studies were missed. Therefore, we conducted an updated meta-analysis of all relevant studies published before May 2019 to more comprehensively analyze the effects of *TCF7L2* rs7903146 polymorphism on individual susceptibility to T2DM in a larger pooled population.

Methods {#Sec2}
=======

The current meta-analysis was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement \[[@CR10]\].

Literature search and inclusion criteria {#Sec3}
----------------------------------------

Potentially relevant articles were searched in PubMed, Medline and Web of Science using the following key words: "TCF7L2", "Transcription Factor 7 Like 2", "polymorphism", "variant", "mutation", "SNP", "genotype", "allele", "type 2 diabetes", "type II diabetes" and "T2DM". The initial literature search was performed in January 2019 and the latest update was finished in May 2019. Moreover, we also screened the references of all retrieved articles to identify other potential relevant studies.

Included studies must meet all the following criteria: (1) genetic association studies on associations between *TCF7L2* rs7903146 polymorphism and T2DM in human beings; (2) provide genotypic/allelic frequency of *TCF7L2* rs7903146 polymorphism in cases and controls; (3) full text in English available. For duplicate reports, only the most complete one was included. Studies were excluded if one of the following criteria was fulfilled: (1) not about *TCF7L2* rs7903146 polymorphism and T2DM; (2) studies that were not performed in human beings; (3) case reports or case series; (4) reviews, comments and conference presentations.

Data extraction and quality assessment {#Sec4}
--------------------------------------

The following data were extracted from included studies: (1) Last name of first author; (2) Year of publication; (3) Country where the study was conducted and ethnicity of study participants; (4) type of disease; (5) the number of cases and controls; and (6) genotypic/allelic distributions of *TCF7L2* rs7903146 polymorphism in cases and controls. The probability value (*p* value) of Hardy--Weinberg equilibrium (HWE) was also calculated. When necessary, we wrote to the corresponding authors for extra information. We used the Newcastle--Ottawa scale (NOS) to assess the quality of eligible studies \[[@CR11]\]. This scale has a score range of zero to nine, and studies with a score of more than seven were thought to be of high quality. Data extraction and quality assessment were performed by two independent reviewers. Any disagreement between two reviewers was solved by discussion until a consensus was reached.

Statistical analyses {#Sec5}
--------------------

We used Review Manager Version 5.3.3 (The Cochrane Collaboration, Software Update) to conduct statistical analyses. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) to estimate strength of associations between *TCF7L2* rs7903146 polymorphism and T2DM in dominant, recessive, over-dominant and allele models. Statistical significances of pooled analyses were determined by the Z test, with a *p* value of 0.05 or less was defined as statistically significant. I^2^ statistics were employed to assess between-study heterogeneities. If I^2^ was greater than 50%, random-effect models (REMs) would be used to pool the data on account of significant heterogeneities. Otherwise, fixed-effect models (FEMs) would be used for synthetic analyses. Subgroup analyses by ethnicity of participants were subsequently performed to evaluate effects of ethnic background on investigated genetic associations. Sensitivity analyses were carried out to test the stability of pooled results by omitting one study each time and re-perform analyses based on the results of the remaining studies. Publication biases were evaluated with funnel plots.

Results {#Sec6}
=======

Characteristics of included studies {#Sec7}
-----------------------------------

The initial literature search found 946 potential relevant articles. After exclusion of irrelevant and duplicate articles by reading titles and abstracts, 278 potentially relevant articles were retrieved for eligibility assessment. Another 210 articles were subsequently excluded after reading the full text. Finally, a total of 68 studies that met the inclusion criteria of our meta-analysis were included (Fig. [1](#Fig1){ref-type="fig"}). Baseline characteristics of included studies were shown in Table [1](#Tab1){ref-type="table"}.Fig. 1Flowchart of study selection for the present study Table 1The characteristics of included studiesFirst author, yearCountryEthnicityType of diseaseSample sizeGenotypes (wtwt/wtmt/mtmt)*p* value for HWENOS scoreCasesControlsrs7903146 C/T Acharya 2015Saudi ArabiaSouth AsianT2DM359/351131/137/91132/143/760.0028 Al-Sinani 2015OmanSouth AsianT2DM992/294NANANA7 Anjum 2018ChinaEast AsianT2DM339/191160/117/62110/56/25\< 0.0017 Assmann 2014BrazilMixedT2DM953/535382/415/156261/215/590.1478 Barra 2012BrazilMixedT2DM113/13949/47/1770/63/60.0767 Barros 2014BrazilMixedT2DM108/10953/49/658/40/110.3047 Beloso 2018UruguayMixedT2DM177/13384/66/2771/47/150.1047 Bielicki 2019PolandCaucasianT2DM121/47969/45/7285/172/220.5397 Bodhini 2007IndiaSouth AsianT2DM1031/1038462/455/114555/391/920.0558 Cai 2019ChinaEast AsianT2DM296/446197/83/16287/147/120.1808 Cauchi 2006FranceCaucasianT2DM2367/2499787/1149/4311208/1060/2310.9448 Chandak 2007IndiaSouth AsianT2DM955/399391/423/141205/160/340.7268 Chang 2007TaiwanEast AsianT2DM760/760NANANA7 Chidambaram 2016IndiaSouth AsianT2DM877/838NANANA7 Corella 2016SpainCaucasianT2DM3411/36071158/1680/5731612/1569/4260.1408 Dahlgren 2017SwedenCaucasianT2DM168/88567/83/18496/327/620.4218 Danquah 2013GermanyCaucasianT2DM674/375273/323/78182/165/280.2577 De Silva 2007UKCaucasianT2DM601/2099211/299/911032/887/1800.5867 El-Lebedy 2016EgyptCaucasianT2DM180/21048/126/6112/95/3\< 0.0018 Erkoç Kaya 2017TurkeyCaucasianT2DM171/12058/95/1857/47/160.2157 Ezzidi 2009TunisiaCaucasianT2DM863/511250/396/217181/235/950.2278 Groves 2006UKCaucasianT2DM2001/2476771/960/2701175/1084/2170.1398 Guewo-Fokeng 2015CameroonAfricanT2DM74/7437/30/737/37/00.0047 Gupta 2010IndiaSouth AsianT2DM195/16155/96/4462/78/210.6478 Hayashi 2007JapanEast AsianT2DM1619/10691450/165/4980/85/20.1468 Horikoshi 2007JapanEast AsianT2DM1174/8231051/119/4770/51/20.2438 Hsiao 2017TaiwanEast AsianT2DM562/986497/62/3933/52/10.7557 Humphries 2016UKCaucasianT2DM1459/2493601/665/1931295/1001/1970.8547 Humphries 2016UKSouth AsianT2DM837/300366/375/96163/111/260.2607 Humphries 2016UKAfricanT2DM307/311141/136/30161/124/260.7597 Hussain 2014IndiaSouth AsianT2DM123/8245/63/1543/35/40.3507 Isakova 2019KyrgyzstanCaucasianT2DM114/10991/20/389/16/40.0098 Jia 2016ChinaEast AsianT2DM248/267125/73/50165/74/28\< 0.0018 Kalantari 2019IranSouth AsianT2DM530/420155/241/134187/173/600.0567 Katsoulis 2018GreeceCaucasianT2DM148/8030/104/1454/23/30.7797 Khan 2015IndiaSouth AsianT2DM42/9813/18/1157/33/80.3127 Khan 2015IndiaSouth AsianT2DM250/25092/120/38144/87/190.2557 Kimber 2007UKCaucasianT2DM3225/32911405/1459/3611714/1329/2480.6638 Kong 2015ChinaEast AsianT2DM5169/4560NANANA7 Kunika 2008JapanEast AsianT2DM1422/14231246/171/51309/111/30.6898 Löfvenborg 2019SwedenCaucasianT2DM1242/1530NANANA7 Marquezine 2008BrazilMixedT2DM285/168183/160/42684/833/164\< 0.0018 Mayans 2007SwedenCaucasianT2DM824/820452/318/54532/253/350.4818 Miranda-Lora 2017MexicoMixedT2DM156/212115/38/3157/51/40.9528 Miyake 2008JapanEast AsianT2DM2154/18341921/228/51696/137/10.2958 Moran 2015VenezuelaAfricanT2DM70/7326/35/946/22/50.3078 Musavi 2015IranSouth AsianT2DM70/10019/36/1545/48/70.2227 Ouhaibi-Djellouli 2014AlgeriaAfricanT2DM76/64416/41/19228/287/1290.0278 Palizban 2017IranSouth AsianT2DM204/8060/95/4932/41/70.2248 Palmer 2011USAMixedT2DM982/1039NANANA7 Papandreou 2019SpainCaucasianT2DM869/244382/383/104106/103/350.2258 Plengvidhya 2018ThailandEast AsianT2DM500/500429/67/4456/44/00.3038 Pourahmadi 2015IranSouth AsianT2DM200/200109/68/23126/59/150.0378 Rees 2008UKSouth AsianT2DM828/432352/360/116222/166/440.1228 Reyes-López 2019MexicoMixedT2DM23/8314/6/359/24/00.1247 Saadi 2008United Arab EmiratesSouth AsianT2DM180/18856/103/2171/94/230.3397 Scott 2006USAMixedT2DM1151/953NANANA7 Tabara 2009JapanEast AsianT2DM481/398434/45/2372/26/00.5018 Turki 2013TunisiaSouth AsianT2DM895/878255/432/208330/414/1340.8247 Uma Jyothi 2015IndiaSouth AsianT2DM758/621341/326/83391/193/370.0487 van Vliet-Ostaptchouk 2007NetherlandsCaucasianT2DM496/907203/221/72459/365/830.3977 Včelák 2012Czech RepublicCaucasianT2DM347/376148/156/43205/147/240.7318 Wang 2013ChinaEast AsianT2DM1842/77771553/283/66718/1032/270.0578 Wrzosek 2019PolandCaucasianT2DM129/34567/50/12219/113/130.7388 Yako 2015South AfricaAfricanT2DM152/32866/74/12184/129/150.1998 Yu 2009USAMixedT2DM686/305355/271/60170/111/240.3308 Zhang 2016ChinaEast AsianT2DM227/5284200/24/34567/701/160.0458 Zheng 2012ChinaEast AsianT2DM227/152202/24/1139/13/00.5828 Zhu 2017ChinaEast AsianT2DM497/782478/19/0740/41/10.5848 Zhuang 2018ChinaEast AsianT2DM90/9654/26/1069/24/30.6117*T2DM* type 2 diabetes mellitus, *wt* Wild type, *mt* mutant type, *HWE* Hardy--Weinberg equilibrium, *NOS* Newcastle--ottawa scale, *NA* not available

TCF7L2 rs7903146 polymorphism and T2DM {#Sec8}
--------------------------------------

The results of overall and subgroup analyses were summarized in Table [2](#Tab2){ref-type="table"}. Totally 68 studies with 115,809 subjects were included for analyses, the pooled analyses showed that *TCF7L2* rs7903146 (dominant model: *p* \< 0.0001, OR = 0.66, 95% CI 0.63--0.70; recessive model: *p* \< 0.0001, OR = 1.64, 95% CI 1.56--1.73; over-dominant model: *p* \< 0.0001, OR = 1.27, 95% CI 1.21--1.34; allele model: *p* \< 0.0001, OR = 0.71, 95% CI 0.68--0.74) polymorphism was significantly associated with susceptibility to T2DM in overall population. Further subgroup analyses revealed similar significant findings in both Asians and Caucasians (Table [2](#Tab2){ref-type="table"}).Table 2Results of overall and subgroup analysesVariablesSample sizeDominant comparisonRecessive comparisonOver-dominant comparisonAllele comparison*p* value OR (95% CI)*p* value OR (95% CI)*p* value OR (95% CI)*p* value OR (95% CI)Overall51,656/64,153*\<* *0.0001 0.66 (0.63--0.70)\<* *0.0001 1.64 (1.56--1.73)\<* *0.0001 1.27 (1.21--1.34)\<* *0.0001 0.71 (0.68--0.74)*Caucasian19,410/23,456*\<* *0.0001 0.64 (0.58--0.70)\<* *0.0001 1.64 (1.54--1.75)\<* *0.0001 1.31 (1.21--1.43)\<* *0.0001 0.70 (0.65--0.75)*East Asian17,607/27,348*\<* *0.0001 0.73 (0.63--0.83)\<* *0.0001 1.90 (1.46--2.46)0.0006 1.28 (1.11--1.48)\<* *0.0001 0.74 (0.66--0.83)*South Asian9326/6730*\<* *0.0001 0.63 (0.59--0.68)\<* *0.0001 1.65 (1.48--1.84)\<* *0.0001 1.24 (1.16--1.33)\<* *0.0001 0.65 (0.60--0.71)OR* odds ratio, *CI* confidence interval, *NA* not available, *T2DM* type 2 diabetes mellitus

Sensitivity analyses {#Sec9}
--------------------

We performed sensitivity analyses by deleting one individual study each time to test the effects of individual study on pooled results. No any altered results were observed in overall and subgroup comparisons, which indicated that our findings were statistically robust.

Publication biases {#Sec10}
------------------

We used funnel plots to assess publication biases. We did not find obvious asymmetry of funnel plots in any comparisons, which suggested that our findings were unlikely to be impacted by severe publication biases (Additional file [1](#MOESM1){ref-type="media"}: Fig. S1).

Discussion {#Sec11}
==========

Despite prominent advancements achieved in drug therapy over the last few decades, T2DM and its associated vascular complications are still leading causes of death and disability around the world \[[@CR12], [@CR13]\]. The exact cause of T2DM is still largely unclear in spite of extensive explorations. However, the obvious familial aggregation tendency of T2DM indicated that genetic factors played significant parts in its pathogenesis \[[@CR14]\]. Thus, identify genetic biomarkers is of particularly importance for an early diagnosis and a better prognosis of T2DM patients.

TCF7L2, a box-containing transcription factor that is vital for blood glucose homeostasis, is considered to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway \[[@CR15]\], and pre-clinical studies also found that TCF7L2 expression is positively associated with insulin gene expression in human islets \[[@CR16]\]. Considering the vital role of TCF7L2 in regulating blood glucose, many genetic association studies were performed in diverse populations to investigate whether functional *TCF7L2* polymorphisms could impact individual susceptibility to T2DM. To our knowledge, this is to date the most comprehensive meta-analysis on association between *TCF7L2* rs7903146 polymorphism and T2DM, and our pooled analyses suggested that *TCF7L2* rs7903146 polymorphism was significantly associated with T2DM in both Asians and Caucasians. The stabilities of synthetic results were evaluated by sensitivity analyses, and no alterations of results were observed in any comparisons, which suggested that our findings were statistically robust. Significant heterogeneities were detected for dominant and allele comparisons, thus pooled analyses for these two genetic models were performed with REMs. But in further subgroup analyses, an obvious reduction tendency of heterogeneity was found in both Asians and Caucasians, which suggested that differences in ethnic background could largely explain observed heterogeneities between studies. Nevertheless, it is worth noting that the obvious heterogeneities existed among included studies indicated that the distribution of *TCF7L2* rs7903146 polymorphism varies greatly from population to population. Therefore, the genetic association between *TCF7L2* rs7903146 polymorphism and T2DM may be ethnic-specific, and we should not generalize the subgroup analyses results to a broader population.

There are several points that need to be pointed out about the current study. First, the exact underlying molecular mechanisms of our positive findings remains to be explored, but we speculated that *TCF7L2* rs7903146 polymorphism may lead to alternations in gene expression or changes in protein structure, which may subsequently affect biological functions of TCF7L2, impact insulin secretion or decrease sensitivity to insulin, and ultimately affect individual susceptibility to T2DM. Second, the pathogenic mechanism of T2DM is extremely complex, and hence despite our positive findings, it is unlikely that a single gene polymorphism could significantly contribute to its development, and thus we strongly recommend further studies to perform haplotype analyses and explore potential gene--gene interactions \[[@CR17], [@CR18]\]. Third, to more precisely measure the effects of certain genetic factors on disease occurrence and development, gene-environmental interactions should also be considered. However, since included studies only focused on the effects of *TCF7L2* rs7903146 polymorphism on individual susceptibility to T2DM, such analyses were not applicable in the current meta-analysis. But to better elucidate the underlying pathogenesis mechanisms of T2DM, future studies should try to investigate the interaction of *TCF7L2* gene polymorphisms with potential pathogenic environmental factors such as unhealthy diets or lack of exercise \[[@CR19]\]. Our meta-analysis certainly has some limitations. Firstly, although methodology qualities of included studies were generally good, it should be noted that we did not have access to genotypic distributions of investigated polymorphisms according to base characteristics of study subjects. Therefore, our results were derived from unadjusted estimations, and failure to conduct further adjusted analyses for baseline characteristics of participants such as age, gender and co-morbidity conditions may influence the veracity of our findings \[[@CR20], [@CR21]\]. Secondly, significant heterogeneities were detected in certain subgroup comparisons, which indicated that the inconsistent results of included studies could not be fully explained by differences in ethnic background, and other unmeasured characteristics of participants may also partially attribute to between-study heterogeneities \[[@CR22]\]. Thirdly, since only published articles were eligible for analyses, although funnel plots revealed no obvious publication biases, we still could not rule out the possibility of potential publication biases \[[@CR23]\]. Taken these limitations into consideration, the results of the current study should be interpreted with caution.

Conclusions {#Sec12}
===========

In conclusion, our findings indicated that *TCF7L2* rs7903146 polymorphism was significantly associated with altered susceptibility to T2DM in both Asians and Caucasians. These results supported that this polymorphism may be used to identify individuals at high risk of developing T2DM in Asians and Caucasians. Further well-designed studies need to explore possible associations between other *TCF7L2* gene polymorphisms and T2DM.

Additional file
===============

 {#Sec13}

**Additional file 1: Figure S1.** Funnel plots.
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